NCT00020046View on ClinicalTrials.gov

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Study Completion Date

September 30, 2003

Conditions
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
Interventions
DRUG

docetaxel

DRUG

thalidomide

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00020046 - Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter